US4624930A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Immunochemical process
Assignee: Roche Diagnostics GmbH
•
Filing: 1983-06-27
•
Granted: 1986-11-25
•
Expires: 2003-06-27
Abstract
Abstract A process for determining the presence of polyvalent antigens by incubation with three receptors is presented. In addition, a kit for carrying out this process is provided as well. One of said receptors is bound to a solid support and the other two, in solution, derive from the same animal species.
Inventors
- 👤 Paul Tanswell
- 👤 Manfred Baier
- 👤 Helmut Lenz
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 23:13
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/74; G01N33/78; G01N33/53; G01N33/543; G01N33/54306; G01N33/563; Y; Y10; Y10S; Y10S435/00; Y10S435/975; Y10S436/00; Y10S436/807; Y10S436/808; Y10S436/811; Y10S436/813; Y10S436/815; Y10S436/817; Y10S436/823; Y10S436/824
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
130 words
A process for the determination of a polyvalent antigen which comprises: incubating a sample containing polyvalent antigen with three different receptors, said first and third receptors being in a liquid phase and comprising an antibody or fragment thereof, wherein said antibodies or fragments thereof derive from the same species, said second receptor being present in a solid phase, the first and third receptors specifically binding to the antigen and said second receptor specifically binding with the first receptor, said third receptor further comprising a marking and not cross-reactive with said first and second receptors; said incubation taking place under conditions favoring formation of antigen receptor complexes, and; separating the liquid and solid phases following complex formation, and measuring the amount of labeled receptor in either the liquid or solid phase.
Claim 2
Dependent Claim
130 words
A process for the determination of a polyvalent antigen which comprises: incubating a sample containing polyvalent antigen with three different receptors, said first and third receptors being in a liquid phase and comprising an antibody or fragment thereof, wherein said antibodies or fragments thereof derive from the same species, said second receptor being present in a solid phase, the first and third receptors specifically binding to the antigen and said second receptor specifically binding with the first receptor, said third receptor further comprising a marking and not cross-reactive with said first and second receptors; said incubation taking place under conditions favoring formation of antigen receptor complexes, and; separating the liquid and solid phases following complex formation, and measuring the amount of labeled receptor in either the liquid or solid phase.
Claim 3
Dependent Claim
14 words
Process according to claim 1, wherein an antibody is used as the first receptor.
Claim 4
Dependent Claim
19 words
Process according to claim 2, wherein an antibody covalently bound with a hapten is used as the first receptor.
Claim 5
Dependent Claim
21 words
Process according to claim 2, wherein a second receptor is used which specifically binds to a part of the first receptor.
Claim 6
Dependent Claim
27 words
Process according to claim 3, wherein a second receptor is used which specifically binds with the F c part or the hapten part of the first receptor.
Claim 7
Dependent Claim
25 words
Process according to claim 2, wherein a separate molecule which is identical to a part of the first receptor is used as the third receptor
Claim 8
Dependent Claim
24 words
Process according to claim 6, wherein said third receptor is a separate molecule which is identical to a Fab fragment of the first receptor.
Claim 9
Dependent Claim
23 words
Process according to claim 1 wherein said third receptor is an antibody which originates from the same animal species as the second receptor.
Claim 10
Dependent Claim
21 words
Process according to claim 8, wherein all three receptors compromise antibodies or fragments thereof which originate from the same animal species.
Claim 11
Dependent Claim
22 words
Process according to claim 1 wherein said third receptor is marked with an enzyme or with a fluorescing, chemiluminescing or radioactive substance.
Claim 12
Dependent Claim
15 words
The process of claim 1 wherein the antigen is incubated simultaneously with all three receptors.
Claim 13
Dependent Claim
37 words
The process of claim 1 wherein the incubating step comprises incubating the antigen with the first and second receptor, whereafter the solid and liquid phases are separated and the solid phase is incubated with the third receptor.
Claim 14
Dependent Claim
86 words
A kit for the determination of a polyvalent antigen comprising first and third different soluble receptors which specifically bind to said antigen, said third receptor carrying a marking, and an insoluble second receptor which specifically binds to said first receptor, wherein said marked, soluble third receptor is a separate molecule identical to a part of said unmarked soluble first receptor and is derived from the same animal species as said first receptor, wherein said three receptors are present in amounts sufficient to determine the polyvalent antigen.
Claim 15
Dependent Claim
86 words
A kit for the determination of a polyvalent antigen comprising first and third different soluble receptors which specifically bind to said antigen, said third receptor carrying a marking, and an insoluble second receptor which specifically binds to said first receptor, wherein said marked, soluble third receptor is a separate molecule identical to a part of said unmarked soluble first receptor and is derived from the same animal species as said first receptor, wherein said three receptors are present in amounts sufficient to determine the polyvalent antigen.
Claim 16
Dependent Claim
37 words
A kit as in claim 13, wherein said first and third receptors comprise an antibody or antibody fragment derived from the same animal species, and said third receptor not cross reacting with the first and second receptors.
References Cited (Backward Citations)
US4343896A
Cited
CA1123336A
Cited
US4048298A
Cited
US4200436A
Cited
US4098876A
Cited
US4397960A
Cited
US4235869A
Cited
EP0008473A1
Cited
US4287300A
Cited
US4281061A
Cited
US4298593A
Cited
US4353982A
Cited
GB2074727A
Cited
US4469796A
Cited
US4376110A
Cited
GB2084317A
Cited
EP0064318A1
Cited
US4469787A
Cited
US4471058A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-11-24 | 1990-05-26 | 1990-11-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-11-24 | 1994-05-26 | 1994-11-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-11-24 | 1998-05-26 | 1998-11-25 | $7700.00 | Window Closed / Lapsed |